Marc Brisson, PhD
Full Professor

Current research aims to develop and utilise mathematical models to study the natural history and transmission dynamics of infectious disease, and to predict the effectiveness and cost-effectiveness of different control strategies and their impact on health inequalities. The work includes epidemiological analysis, mathematical modelling, valuation of outcomes (i.e. QALYs gained), and economic analysis.

March 2019
PUBLICATION IN THE LANCET ONCOLOGY:'Global elimination of cervical cancer as a public health problem' [ ScienceDirect ]
February 2019
ACIP MEETING. Marc Brisson was presenting at the meeting of the Advisory Committee on Immunization Practices (ACIP): ’Cost-Effectiveness of extending HPV vaccination above age 26 years in the U.S’ (Atlanta, February 27) [ Meeting Agenda ]
December 2018
EUROGIN 2018. Marc Brisson was chair of the session 'Two vs one dose vaccine schedules: assessing the evidence' at EUROGIN 2018 and was invited speaker presenting 'Population-level impact of 1-dose vaccination in Low and Middle Income Countries vs High Income Countries: Model-based analysis'. (Lisbon, December 2-5)[ EUROGIN 2018 - PROGRAM (PDF) ]
December 2018
EUROGIN 2018. Philippe Lemieux-Mellouki was presenting at EUROGIN 2018: ‘Impact of changes in sexual behavior on past and future trends of HPV infections and related cancers.’ (Lisbon, December 2-5) [ EUROGIN 2018 - PROGRAM (PDF) ]
October 2018
SAGE-WHO MEETING. Élodie Bénard and Dave Martin were present at the meeting of the WHO Strategic Advisory Group of Experts (SAGE) on immunization held October 23-25, 2018, in Geneva.

Admin panel